An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 4, 2012, Pages 331-338

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

KIT; PDGFRA; Small cell lung carcinoma

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

AGED; ARTICLE; ENZYMOLOGY; EXON; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMALL CELL CARCINOMA; TIME;

AGED; CARCINOMA, SMALL CELL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864307120     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. LaPoint RJ, Bourne PA, Wang HL, Xu H. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. Appl Immunohistochem Mol Morphol 2007; 15: 401-406.
2. Lopes-Martin A, Ballenstin C, Garcia-Carbonero R, Castano A, Lopez-Rios F, Lopes-Encuentra A, Sanchez-Cespedes M, Castellano D, Bartolomes A, Cortes Funes H, Paz-Ares L. Prognostic value of KIT expression in small cell lung carcinoma. Lung Cancer 2007; 56: 405-413.
3. Micke P, Basral M, Faldum A, Bittinger F, Ronnstrand L, Blaukat A, Beeh KM, Oesch F, Fischer B, Buhl R, Hengstler JG. Characterization of ckit expression in small cell lung carcinoma: prognostic and therapeutic implications. Clin Cancer Res 2003; 9: 188-194.
4. Camps C, Sirera R, Bremnes RM, Garde J, Safont MJ, Blasco A, Berrocal A, Sanchez JJ, Calabuig C, Marrorell M. Analysis of c-kit expression in small cell lung carcinoma: prevalence and prognostic implications. Lung Cancer 2006; 52: 343-347.
5. Rossi G, Cavazza A, Marchioni A, Miggaldi M, Bavierli M, Fracciolongo N, Petruzzelli S, Longo L, Tamberi S, Crino L. KIT expression in small cell carcinoma of the lung: effects of chemotherapy. Mod Pathol 2003; 16: 1041-1047.
6. Naeem M, Dahiya M, Clark JI, Creech SD, Alkin S. Analysis of c-kit protein expression in smallcell lung carcinoma and its implications for prognosis. Hum Pathol 2002; 33: 1182-1187.
7. Mojica WD, Saxena R, Starostik P, Cheney RT. CD117 + small cell lung cancer lacks the asp 816 val point mutation in exon 17. Histopathology 2005; 47: 517-522.
8. Boldrini L, Ursino S, Gisfredi S, Faviana P, Donati V, Camcci T, Lucchi M, Mussi A, Basolo F, Pingitore R. Fontanini G. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Clin Cancer Res 2004; 15: 4101-4108.
9. Burger H, Den Bakker MA, Stoter G, Verweij J, Nooter K. Lack of c-kit exon 11 activating mutations in c-kit/CD117-positive SCLC tumor specimens. Eur J Cancer 2003; 39: 793-799.
10. Sihto H, Sarlomo-Rikara M, Tynnienen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 2005; 23: 49-57.
11. Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol Int 2006; 56: 1-9.
12. Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diang Pathol 2006; 23: 91-101.
13. Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478.
14. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shimomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science 1998; 279: 577-580.
15. Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y. Gain-offunction mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology 2003; 125: 660-667.
16. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissue, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005: 13: 205-220.
17. Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 2002; 52: 740-746.
18. Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 2005; 271: 271-275.
19. Terada T, Tanigichi M. Intraductal oncocytic papillary neoplasm of the liver. Pathol Int 2004; 54: 116-123.
20. Terada T. Ductal adenoma of the breast: Immunohistochemistry of two cases. Pathol Int 2008; 58: 801-805.
21. Gown AM, Goldstein LC, Barry TS, Kussick SJ, Kandalaft PL, Kim PM, Tse CC. High concordance between immunohistochemistry and fluolescent in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system. Mod Pathol 2008; 21: 1272-1277.
22. Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of ckit and PDGFRA genes. Int J Gynecol Pathol 2009; 28; 29-34.
23. Terada T. Primary extragastrointestinal stromal tumors of the transverse mesocolon without ckit mutations but with PDGFRA mutations. Med Oncol 2009; 26: 233-237.
24. Terada T. Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of c-kit gene. Would J Gastroenterol 2008; 14: 7256-7259.
25. Terada T. Mediastinal seminoma with multiple KIT gene mutations. Pathology 2009; 41: 695-697.
26. Terada T. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study. Appl Immunohisto-Chem Mol Morphol 2011; 19; 450-453.
27. Terada T. Primary small cell carcinoma of the mediastinum: A case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009; 26: 247-250.
28. Terada T. Primary small cell carcinoma of the ureter: A case report involving immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Pathology 2010; 42: 101-102.
29. Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol Int 2009; 59: 247-250.
30. Terada T. KIT and PDGFRA in esophageal small cell carcinoma. Int J Clin Exp Pathol 2011; 4: 718-721.
31. Terada T. Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases. Int J Clin Oncol 2010; 15; 453-456.
32. Terada T. Amelanotic malignant melanoma of the esophagus: report of two cases with immunohistocheimcal and molecular genetic study of KIT and PDGFRA. World J Gastroenterol 2009: 15: 2679-2683.
33. Terada T. Gastrointestinal stromal tumor of the digestive organs: a histopathologic study of 31 cases in a single Japanese institute. Int J Clin Exp Pathol 2010: 3: 162-168.
34. Terada T. Primary small cell carcinoma of the pleura: A case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2010; 27: 1119-1122.
35. Terada T. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract 2010; 206: 420-425.
36. Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Muller W, Steidl U, Fenk R, Graf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R. Expression of the tyrosine kinase ckit is an independent prognostic factor in patients with small cell lung cancer. Int J Cancer 2004; 20: 259-263